<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7533519</article-id><article-id pub-id-type="pmc">2033638</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alfieri</surname><given-names>A. B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cubeddu</surname><given-names>L. X.</given-names></name></contrib></contrib-group><aff>Department of Pharmacology, School of Pharmacy, Central University of Venezuela.</aff><pub-date pub-type="ppub"><month>3</month><year>1995</year></pub-date><volume>71</volume><issue>3</issue><fpage>629</fpage><lpage>632</lpage><abstract><p>To test the role of serotonin in chemotherapy-induced nausea and emesis, ten cancer patients were pretreated with the serotonin synthesis inhibitor para-chlorophenylalanine (PCPA). PCPA (2 g 8 hourly for 2 or 3 days prior to cisplatin) reduced the spontaneous urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA), inhibited the increase in urinary 5-HIAA induced by cisplatin and markedly attenuated the acute period of nausea and vomiting associated with the cytotoxic drug. These results indicate that gastrointestinal serotonin mediates cisplatin-induced emesis and that the amount of serotonin released by cisplatin is a major factor in determining the severity of the acute period of emesis experienced by the patient.</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00049-0203.tif" xlink:title="scanned-page" xlink:role="629" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00049-0204.tif" xlink:title="scanned-page" xlink:role="630" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00049-0205.tif" xlink:title="scanned-page" xlink:role="631" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00049-0206.tif" xlink:title="scanned-page" xlink:role="632" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

